Publicou 6 edições por ano
ISSN Imprimir: 1040-8401
ISSN On-line: 2162-6472
Indexed in
Tumor Plasticity Interferes with Anti-Tumor Immunity
RESUMO
Since tumor cell plasticity was first shown to be crucial in tumor promotion and immune surveillance evasion, it has become an issue of intense investigation. Several mechanisms are associated with the acquisition of tumor cell plasticity and immune evasion, including loss of epithelial phenotype through epithelial-to-mesenchymal transition (EMT). We discuss recent evidence revealing that tumor cell plasticity may lead to the emergence of immunoresistant variants and how the tumor microenvironment evolves to shape this plasticity. We argue that targeting carcinoma cell plasticity represents a novel strategy to better control the emergence of resistant variants and to ensure more effective cancer therapies. In this context, the design of innovative integrative immunotherapy approaches is warranted.
-
Vuillefroy de Silly Romain, Ducimetière Laura, Yacoub Maroun Céline, Dietrich Pierre-Yves, Derouazi Madiha, Walker Paul R., Phenotypic switch of CD8+T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells, European Journal of Immunology, 45, 8, 2015. Crossref
-
Banyard Jacqueline, Bielenberg Diane R., The role of EMT and MET in cancer dissemination, Connective Tissue Research, 56, 5, 2015. Crossref
-
Nieto M. Angela, Huang Ruby Yun-Ju, Jackson Rebecca A., Thiery Jean Paul, EMT: 2016, Cell, 166, 1, 2016. Crossref
-
Dominguez Charli, Tsang Kwong-Yok, Palena Claudia, Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies, Cell Death & Disease, 7, 9, 2016. Crossref
-
Ferreira Bibiana I., Lie Maria K., Engelsen Agnete S. T., Machado Susana, Link Wolfgang, Lorens James B., Adaptive mechanisms of resistance to anti-neoplastic agents, MedChemComm, 8, 1, 2017. Crossref
-
Janji Bassam, Viry Elodie, Mgrditchian Takouhie, Arakelian Tsolere, Medves Sandrine, Berchem Guy, Autophagy Activation in the Tumor Microenvironment, in Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, 2016. Crossref
-
Iser Isabele C., Pereira Mariana B., Lenz Guido, Wink Márcia R., The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation, Medicinal Research Reviews, 37, 2, 2017. Crossref
-
Raimondi Cristina, Carpino Guido, Nicolazzo Chiara, Gradilone Angela, Gianni Walter, Gelibter Alain, Gaudio Eugenio, Cortesi Enrico, Gazzaniga Paola, PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?, OncoImmunology, 6, 12, 2017. Crossref
-
Lindsay Danika, Garvey Colleen M., Mumenthaler Shannon M., Foo Jasmine, The Response of Cancer Cell Populations to Therapies, in Ecology and Evolution of Cancer, 2017. Crossref
-
Vanneste Marion, Henry Michael D., Targeting Phenotypic Plasticity in Prostate Cancer, Current Molecular Biology Reports, 3, 3, 2017. Crossref
-
Ziani Linda, Chouaib Salem, Thiery Jerome, Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts, Frontiers in Immunology, 9, 2018. Crossref
-
Lachat Camille, Boyer-Guittaut Michaël, Peixoto Paul, Hervouet Eric, Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2, Epigenomes, 3, 1, 2018. Crossref
-
Engl Wilfried, Viasnoff Virgile, Thiery Jean Paul, Epithelial Mesenchymal Transition Influence on CTL Activity, in Resistance of Cancer Cells to CTL-Mediated Immunotherapy, 7, 2015. Crossref
-
Soundararajan Rama, Fradette Jared, Konen Jessica, Moulder Stacy, Zhang Xiang, Gibbons Don, Varadarajan Navin, Wistuba Ignacio, Tripathy Debasish, Bernatchez Chantale, Byers Lauren, Chang Jeffrey, Contreras Alejandro, Lim Bora, Parra Edwin, Roarty Emily, Wang Jing, Yang Fei, Barton Michelle, Rosen Jeffrey, Mani Sendurai, Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy, Cancers, 11, 5, 2019. Crossref
-
Hasmim Meriem, Messai Yosra, Terry Stéphane, Janji Bassam, Noman Muhammad Zaeem, Chouaib Salem, Hypoxia: A Formidable Saboteur of the Anti-tumor Response, in Resistance of Cancer Cells to CTL-Mediated Immunotherapy, 7, 2015. Crossref
-
Noman Muhammad Zaeem, Hasmim Meriem, Lequeux Audrey, Xiao Malina, Duhem Caroline, Chouaib Salem, Berchem Guy, Janji Bassam, Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges, Cells, 8, 9, 2019. Crossref
-
Manjunath Yariswamy, Upparahalli Sathisha V., Avella Diego M., Deroche Chelsea B., Kimchi Eric T., Staveley-O’Carroll Kevin F., Smith Charles J., Li Guangfu, Kaifi Jussuf T., PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer, Cancers, 11, 6, 2019. Crossref
-
Behren Andreas, Thompson Erik W., Anderson Robin L., Ferrao Petranel T., Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response, Frontiers in Oncology, 9, 2019. Crossref
-
Janji Bassam, Viry Elodie, Moussay Etienne, Paggetti Jérôme, Arakelian Tsolère, Mgrditchian Takouhie, Messai Yosra, Noman Muhammad Zaeem, Van Moer Kris, Hasmim Meriem, Mami-Chouaib Fathia, Berchem Guy, Chouaib Salem, The multifaceted role of autophagy in tumor evasion from immune surveillance, Oncotarget, 7, 14, 2016. Crossref
-
Lim Jaeseung, Harnessing Natural Killer Cells’ Killing Function in Cancer, in Second Generation Cell and Gene-based Therapies, 2020. Crossref
-
Genna Anthony, Vanwynsberghe Aline M., Villard Amélie V., Pottier Charles, Ancel Julien, Polette Myriam, Gilles Christine, EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis, Cancers, 12, 6, 2020. Crossref
-
Tittarelli Andrés, Navarrete Mariela, Lizana Marcelo, Hofmann-Vega Francisca, Salazar-Onfray Flavio, Hypoxic Melanoma Cells Deliver microRNAs to Dendritic Cells and Cytotoxic T Lymphocytes through Connexin-43 Channels, International Journal of Molecular Sciences, 21, 20, 2020. Crossref
-
Richter Camden, Mayhew David, Rennhack Jonathan P., So Jonathan, Stover Elizabeth H., Hwang Justin H., Szczesna-Cordary Danuta, Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer, International Journal of Molecular Sciences, 21, 22, 2020. Crossref
-
Bravaccini Sara, Bronte Giuseppe, Petracci Elisabetta, Puccetti Maurizio, D’Arcangelo Manolo, Ravaioli Sara, Tumedei Maria Maddalena, Maltoni Roberta, Delmonte Angelo, Cappuzzo Federico, Crinò Lucio, The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects, Frontiers in Cell and Developmental Biology, 9, 2021. Crossref
-
Wu Tiantian, Tang Caijin, Tao Renchuan, Yong Xiangzhi, Jiang Qiaozhi, Feng Cong, PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers, Frontiers in Immunology, 12, 2021. Crossref
-
Drak Alsibai Kinan, Cancer Metabolic and Immune Reprogramming: The Intimate Interaction Between Cancer Cells and Microenvironment, Journal of Cancer Prevention & Current Research, 1, 2, 2014. Crossref
-
Bronte Giuseppe, Puccetti Maurizio, Petracci Elisabetta, Landi Lorenza, Cravero Paola, Scodes Simona, Ulivi Paola, Ravaioli Sara, Tumedei Maria Maddalena, Burgio Marco Angelo, Cappuzzo Federico, Delmonte Angelo, Crinò Lucio, Bravaccini Sara, The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer, Frontiers in Oncology, 11, 2021. Crossref
-
Tittarelli Andrés, Janji Bassam, Van Moer Kris, Noman Muhammad Zaeem, Chouaib Salem, The Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing, Journal of Biological Chemistry, 290, 39, 2015. Crossref
-
Lin Huey-Jen, Liu Yingguang, Lofland Denene, Lin Jiayuh, Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity, Cancers, 14, 2, 2022. Crossref
-
Tripathi Satyendra C., Peters Haley L., Taguchi Ayumu, Katayama Hiroyuki, Wang Hong, Momin Amin, Jolly Mohit Kumar, Celiktas Muge, Rodriguez-Canales Jaime, Liu Hui, Behrens Carmen, Wistuba Ignacio I., Ben-Jacob Eshel, Levine Herbert, Molldrem Jeffrey J., Hanash Samir M., Ostrin Edwin J., Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome, Proceedings of the National Academy of Sciences, 113, 11, 2016. Crossref
-
Ge Yang, Liu Heshu, Zhang Yuanyuan, Liu Jian, Yan Rui, Xiao Zeru, Fan Xiaona, Huang Xuying, An Guangyu, Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma, Translational Oncology, 17, 2022. Crossref
-
Saxena Kritika, Subbalakshmi Ayalur Raghu, Kulkarni Prakash, Jolly Mohit Kumar, Cancer: More than a geneticist’s Pandora’s box, Journal of Biosciences, 47, 2, 2022. Crossref
-
Lotsberg Maria L., Davidsen Kjersti T., D’Mello Peters Stacey, Haaland Gry S., Rayford Austin, Lorens James B., Engelsen Agnete S. T., The Role of AXL Receptor Tyrosine Kinase in Cancer Cell Plasticity and Therapy Resistance, in Biomarkers of the Tumor Microenvironment, 2022. Crossref
-
Chen Gaoqi, Wu Kaiwen, Li Hao, Xia Demeng, He Tianlin, Role of hypoxia in the tumor microenvironment and targeted therapy, Frontiers in Oncology, 12, 2022. Crossref